Balyasny Asset Management’s Relmada Therapeutics RLMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$2.65M Buy
2024
Q2
Sell
2024
Q1
$57.3K Buy
2022
Q4
Sell
2022
Q3
$11.4M Buy
2022
Q2
$4.53M Buy